- Issuer ticker
-
CLB
- Reported as of
-
01 Dec 2023
- Net transaction value
-
-$976
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
04 Dec 2023, 16:51:14 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Mark Tattoli, Attorney-in-Fact
Key filing fact
Kevin Daniels filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 04 Dec 2023.
Key facts
- This page summarizes Kevin Daniels's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Dec 2023, 16:51.
Change
- Previous filing in this sequence was filed on 21 Feb 2023.
- Current net transaction value: -$976.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLB
transaction
Common Stock
Tax liability
- Transaction value
- $976
- Shares
- -54
- Change %
- -0.61%
- Price
-
$18.07
- Shares after
- 8,749
- Date
- 01 Dec 2023
- Ownership
- Direct
CLB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +140
- Change %
- +1.6%
- Price
-
$0.000000
- Shares after
- 8,803
- Date
- 01 Dec 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLB
transaction
Derivative
Restricted Shares
Options Exercise
- Transaction value
- $0
- Shares
- -140
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 01 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 140
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote